Axogen Financial Ratios
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Axogen ratio analysis
Axogen earned a net margin of -7.0% in FY 2025, down from -5.3% a year earlier. Gross margin was 74.3% compared with a median of 82.0% over the prior 9 years. Return on equity reached -12.2%, meaning Axogen generated -0.12 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.38 versus 0.46 the year before, and the current ratio was 5.11. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Axogen financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 6.34 | 3.81 | 1.84 | 3.03 | 3.03 | 6.37 | 6.04 | 9.43 | 0.02 | 0.01 |
| Price / book | 11.08 | 6.86 | 3.06 | 4.16 | 3.43 | 5.81 | 4.88 | 5.38 | 0.04 | 0.02 |
| Gross margin | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% | 80.8% | 83.7% | 84.6% | 84.6% | 84.3% |
| Operating margin | -3.5% | -1.8% | -13.5% | -21.4% | -20.0% | -20.6% | -29.4% | -24.4% | -13.2% | -19.8% |
| Net margin | -7.0% | -5.3% | -13.7% | -20.9% | -21.2% | -21.2% | -27.3% | -26.7% | -17.3% | -35.1% |
| Free cash flow margin | -1.3% | 0.8% | -12.3% | -26.1% | -32.4% | -28.1% | -23.0% | -28.8% | -17.1% | -29.6% |
| Return on equity (ROE) | -12.2% | -9.6% | -22.7% | -28.7% | -24.0% | -19.3% | -22.0% | -15.2% | -41.5% | -96.6% |
| Return on assets (ROA) | -7.1% | -4.9% | -11.0% | -14.8% | -13.0% | -11.8% | -18.8% | -14.0% | -17.7% | -31.1% |
| Debt / equity | 0.38 | 0.46 | 0.49 | 0.45 | 0.40 | 0.26 | 0.01 | 0.00 | 0.82 | 1.36 |
| Current ratio | 5.11 | 3.24 | 2.89 | 4.13 | 5.23 | 6.36 | 6.47 | 11.57 | 4.06 | 3.97 |
| Revenue growth | 20.2% | 17.8% | 14.7% | 8.8% | 13.4% | 5.2% | 27.1% | 38.9% | 47.0% | 50.4% |